FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 313:1178-1181 November 7, 1985 Number 19 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Pseudohypoaldosteronism, a syndrome characterized by salt wasting and failure to thrive, usually presents in infancy as high urinary levels of sodium despite hyponatremia, hyperkalemia, hyperreninemia, and elevated aldosterone levels. We have investigated this syndrome for the possibility of abnormal Type I or "mineralocorticoid-like" receptors, which have intrinsic steroid specificity indistinguishable from that of renal mineralocorticoid receptors and are found in many tissues and cells, including mononuclear leukocytes. We have studied three patients with pseudohypoaldosteronism: the 28-year-old index case in Melbourne (Patient 1) and two siblings in Munich, eight and two years of age (Patients 2 and 3); clinically, Patient 3 had a less severe case than his sister. Percoll-separated control monocytes bound [3H]aldosterone with high affinity (Kd approximately 3 nM) and limited capacity (150 to 600 sites per cell). On repeated examination, no [3H]aldosterone binding was found in monocytes from Patients 1 and 2; in Patient 3, the levels were 62 sites per cell, more than 2 S.D. below those of the control. Levels in the parents of the Munich patients (first cousins) were normal. It appears that pseudohypoaldosteronism is caused by a Type I receptor defect, that the defect may be complete or partial, that transmission may be autosomal recessive, and that the study of patients with pseudohypoaldosteronism may indicate physiologic roles for Type I receptors in nonepithelial tissues.

This article has been cited by other articles:

• Riepe, F. G., Krone, N., Morlot, M., Ludwig, M., Sippell, W. G., Partsch, C.-J. (2003). Identification of a Novel Mutation in the Human Mineralocorticoid Receptor Gene in a German Family with Autosomal-Dominant Pseudohypoaldosteronism Type 1: Further Evidence for Marked Interindividual Clinical Heterogeneity. J. Clin. Endocrinol. Metab. 88: 1683-1686 [Abstract] [Full Text]  
• Herrington, D. M., Howard, T. D., Hawkins, G. A., Reboussin, D. M., Xu, J., Zheng, S. L., Brosnihan, K. B., Meyers, D. A., Bleecker, E. R. (2002). Estrogen-Receptor Polymorphisms and Effects of Estrogen Replacement on High-Density Lipoprotein Cholesterol in Women with Coronary Disease. NEJM 346: 967-974 [Abstract] [Full Text]  
• Fujisawa, G., Dilley, R., Fullerton, M. J., Funder, J. W. (2001). Experimental Cardiac Fibrosis: Differential Time Course of Responses to Mineralocorticoid-Salt Administration. Endocrinology 142: 3625-3631 [Abstract] [Full Text]  
• Arai, K., Zachman, K., Shibasaki, T., Chrousos, G. P. (1999). Polymorphisms of Amiloride-Sensitive Sodium Channel Subunits in Five Sporadic Cases of Pseudohypoaldosteronism: Do They Have Pathologic Potential?. J. Clin. Endocrinol. Metab. 84: 2434-2437 [Abstract] [Full Text]  
• Hughes, M., Malloy, P., Kieback, D., Kesterson, R., Pike, J., Feldman, D, O'Malley, B. (1988). Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 242: 1702-1705 [Abstract]  
• Arriza, J., Weinberger, C, Cerelli, G, Glaser, T., Handelin, B., Housman, D., Evans, R. (1987). Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237: 268-275 [Abstract]